Consortium Recommends Sanger Sequencing For Salmon Genome After 454's FLX Fails Test | GenomeWeb
An international research consortium that plans to start sequencing the Atlantic salmon genome early next year expects to conduct the first phase of the project with Sanger sequencing technology after a review of Roche/454 Life Sciences' Genome Sequencer FLX technology last year, which generated an assembly of insufficient quality.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.